Search Within

Jaap Jan Boelens

  1. "Bone Marrow Transplant"
Formats
  1. Meeting Abstract (13)
  2. Journal Article (10)
  3. Correspondence (2)
  4. Editorial (2)
  5. Guidelines (1)
Groups
  1. Bone Marrow Transplant (28)
  2. Center for Hematologic Malignancies (28)
  3. Department of Medicine (28)
  4. Hematologic Malignancies, Division of (28)
  5. Pediatrics, Department of (28)
  6. Stem Cell Transplantation and Cellular Therapy Service (28)

More Groups

People
  1. Miguel-Angel Perales (23)
  2. Sergio Giralt (18)
  3. Michael Scordo (14)
  4. Richard O'Reilly (13)
  5. Kevin Curran (12)
  6. Roni Tamari (11)

More People

Years
  1. 2025 (2)
  2. 2024 (7)
  3. 2023 (4)
  4. 2022 (5)
  5. 2021 (1)
  6. 2020 (6)

More Years

Publications
  1. Biology of Blood and Marrow Transplantation (6)
  2. Blood (6)
  3. Bone Marrow Transplantation (6)
  4. Blood Advances (4)
  5. Transplantation and Cellular Therapy (2)
  6. Clinical Pharmacokinetics (1)

More Publications

Publishers
  1. American Society of Hematology (10)
  2. Elsevier Inc. (8)
  3. Nature Publishing Group (7)
  4. Adis International Ltd (1)
  5. Elsevier Science Ltd. (1)
  6. Elsevier Science, Inc. (1)

Results (28)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Population pharmacokinetic estimation of ATG exposure predicts immune reconstitution and survival in adults undergoing ex vivo CD34-selected allogeneic hematopoietic cell transplantation
    Meeting Abstract

    Scordo, M.; Cho, C.; Devlin, S. M.; Maloy, M. A.; Ruiz, J. D.; Bhatt, V.; Smith, M.; O'Reilly, R. J.; Papadopoulos, E. B.; Jakubowski, A. A.; more...
    Bone Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Response to Kawedia et al letter to editor in response to the article by McCune et al ''Harmonization of busulfan plasma exposure unit (BPEU): A community-initiated consensus statement''
    Correspondence

    Dupuis, L. L.; Quinones, C. M.; Ritchie, J.; Carpenter, P. A.; Bauters, T.; Yeh, R. F.; Anasetti, C.; Boelens, J. J.; Hamerschlak, N.; Hassan, M.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Time-driven activity-based costing (TDBAC) identifies time and effort required for completion of CIBMTR forms and can assist in resource planning for HCT centers
    Meeting Abstract

    Gonzalez, M.; Klein, E.; Maloy, M. A.; Fuller, K.; Boelens, J. J.; Giralt, S. A.; Kernan, N. A.; Perales, M.
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Population pharmacokinetic model demonstrates poor outcomes with ATG overexposure in adults undergoing ex vivo CD34-selected allogeneic hematopoietic cell
    Meeting Abstract

    Scordo, M.; Cho, C.; Devlin, S. M.; Maloy, M. A.; Ruiz, J. D.; Bhatt, V.; Smith, M.; Shah, G. L.; O'Reilly, R. J.; Papadopoulos, E. B.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Durable remission following "off-the-shelf" chimeric antigen receptor (CAR) T-cells in patients with relapse/refractory (R/R) B-cell malignancies
    Meeting Abstract

    Curran, K. J.; Sauter, C. S.; Kernan, N. A.; Prockop, S. E.; Boulad, F.; Perales, M.; Giralt, S. A.; Riviere, I.; Wang, X.; Boelens, J. J.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Toxicity and response after CD19-specific CAR T-cell therapy in pediatric/young adult relapsed/refractory B-ALL
    Journal Article

    Curran, K. J.; Margossian, S. P.; Kernan, N. A.; Silverman, L. B.; Williams, D. A.; Shukla, N.; Kobos, R.; Forlenza, C. J.; Steinherz, P.; Prockop, S.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Harmonization of busulfan plasma exposure unit (BPEU): A community-initiated consensus statement
    Journal Article

    McCune, J. S.; Quinones, C. M.; Ritchie, J.; Carpenter, P. A.; van Maarseveen, E.; Yeh, R. F.; Anasetti, C.; Boelens, J. J.; Hamerschlak, N.; Hassan, M.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Standard antithymocyte globulin dosing results in poorer outcomes in overexposed patients after ex vivo CD34(+) selected allogeneic hematopoietic cell transplantation
    Journal Article

    Scordo, M.; Bhatt, V.; Hilden, P.; Smith, M.; Thoren, K.; Cho, C.; Shah, G. L.; Maloy, M. A.; Papadopoulos, E. B.; Jakubowski, A. A.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save